■ DETERMINING CURRENT HEALTH STATUS

Health interview
The most important element of cardiac risk evaluation is the health interview because information on the patient's history and current status will serve as the basis for most of our decisions and actions.
History. A history of cardiovascular disease--particularly myocardial infarction (MI), angina, congestive heart failure (CHF), arrhythmia, or valvular disease--is obviously significant. In such cases, ascertain the type of diagnostic and therapeutic procedures the patient has already undergone, when and where they were performed, and the specific results.
There is little value to knowing that the results of a previous test were "okay." With regard to stress testing, we need specific information on, for example, the patient's peak heart rate, peak systolic pressure, and rate pressure product (RPP). The "ischemic threshold" is a very reproducible value in an individual patient. It is important to anesthesiologists because a patient is less likely to experience ischemia during surgery if the anesthesiologist can keep the RPP from exceeding this threshold. If the patient previously underwent a thallium stress test, we need to know about any reperfusion abnormalities, including the number of segments involved and their distribution. Important findings on echocardiography include wall-motion abnormalities, ejection fraction, and valvular anatomy and function. If the patient has undergone cardiac catheterization, knowledge of the presence of left main coronary artery disease or triple-vessel disease is not only vital before surgery but is also an independent indication for revascularization even if surgery had not been planned. Finally, we need to know if the patient has undergone revascularization procedures.
Current medical status. Significant risk factors for cardiac disease are diabetes, hypertension, hyperlipidemia, and cigarette smoking. The presence of other concomitant conditions--eg, peripheral vascular disease, cerebrovascular disease, chronic renal insufficiency, and chronic obstructive pulmonary disease (COPD)--may place patients at a higher risk for cardiac disease and perioperative complications than they otherwise would be.
Another important issue is the patient's functional status. Key factors include chest pain and shortness of breath as well as the patient's functional capacity. I specifically ask patients how many blocks they can walk and how many flights of stairs they can climb Cardiac risk stratification before noncardiac surgery without stopping. Do not underestimate the severity of risk in home-bound patients who report no chest pain or shortness of breath; the amount of stress that they will experience during surgery (other than a minor procedure) will probably exceed the amount they exert during activities of daily living.
Age. Age may serve as a marker for decreased cardiac reserve or subclinical disease, but by itself has only minor significance.
Physical examination
If the patient provides thorough and honest answers during the health interview, the typical physical examination will usually serve only to confirm what is already known about the patient's current status. Potentially important findings include the following:
• Vital signs (arrhythmias, uncontrolled hypertension) • A murmur (aortic stenosis, in particular) • A third heart sound, jugular venous distention, or rales (heart failure).
Electrocardiography
Electrocardiography (ECG) is typically performed prior to surgery, but it rarely changes the management approach. For example, detecting a conduction defect, bundle branch block, left ventricular hypertrophy, or nonspecific changes in ST-T waves on ECG will not have any impact on surgical decisions. Finding Q waves in a patient with a history of an MI only confirms it. At best, an ECG will detect evidence of a recent silent MI, but this is rare. Finally, most arrhythmias are discovered on physical examination prior to ECG.
■ RISK STRATIFICATION
Based on the history, physical examination, and ECG, patients can be categorized as being in a lowrisk, intermediate-risk, or high-risk group. High-risk patients should be considered for further therapy and evaluation, including invasive testing. A noninvasive test in such a patient often adds little to what is already known. Moreover, a negative result on a noninvasive test is not as reliable in a high-risk patient because the result is more likely to be a false negative in this setting.
Intermediate-risk patients are numerous and their risk can be refined either up or down depending on the rigor of further evaluation. One option for such patients is additional testing; another is to proceed with surgery after initiating a trial of prophylactic medical therapy. 
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Minor clinical predictors are advanced age, nonspecific ECG abnormalities, nonsinus rhythm, cerebrovascular disease, and uncontrolled hypertension.
Patients with minor predictors also should undergo a METs assessment. Those with a moderate or good score can proceed to surgery, while others may or may not be candidates for noninvasive testing or medical therapy, depending on the surgical risk.
Surgery-specific risk. Different types of surgery are classified simply as high-, intermediate-, and low-risk.
High-risk surgeries are those associated with a predicted cardiac complication rate greater than 5%. These include major emergency surgery, procedures to correct aortic disease or significant peripheral vascular disease, and other prolonged procedures that involve significant fluid shifts, fluid administration, or blood loss. Most patients undergoing high-risk surgery should either undergo noninvasive testing or receive medical therapy, depending on their clinical predictors.
Intermediate-risk surgeries (expected cardiac complication rate of 1% to 5%) include carotid endarterectomy (which is classified separately from other vascular procedures because newer surgical techniques have lowered its risk), major head and neck operations, major joint replacement, repair of hip fracture, and intraperitoneal, intra-abdominal, and intrathoracic procedures. Open or radical prostatectomies are included in this list. Patients with adequate functional capacity (and no major clinical predictor) can undergo intermediate-risk surgery without further testing.
Low-risk surgeries (expected cardiac complication rate < 1%) are those that do not involve invasion of a body cavity, such as endoscopic procedures and superficial excisions. The risk of complications associated with these procedures is generally lower than the risk of preoperative cardiac testing and subsequent intervention, so adherence to the dictum "first do no harm" calls for allowing patients to proceed to these types of surgeries without testing.
Exercise capacity. The METs classification is used to determine exercise capacity. It is a fairly subjective evaluation. I consider a patient to be at risk if he or she cannot perform tasks that are assigned a METs value of 4 or less (Table 1) . I generally ask patients how many blocks they can walk and how many flights of stairs they can climb without stopping. I consider patients to be at low (or at least acceptable) risk if they can walk at least three blocks and climb one flight of stairs without difficulty.
However, patient self-reports of exercise capacity are not always reliable, so when there is doubt, you can walk the patient up and down the hall or stairs to see firsthand what the patient can do.
ACC guideline shortcut for noninvasive testing. In general, noninvasive testing is indicated in the presence of two of the following three negative factors: intermediate or major clinical predictors, highrisk surgery, and poor exercise capacity.
ACP guidelines
The two main elements of the ACP guidelines 3 are the Detsky modified cardiac risk index and a list of "low-risk variables." Patients are first evaluated according to the Detsky criteria, and if they are found not to be at high risk, they are then evaluated according to the low-risk variables criteria.
Detsky index. This cardiac risk index was developed by Detsky et al and published in 1986. 5 A score of 20 points or more indicates high risk; point values are assigned for each of the following conditions:
• MI within 6 months (10 points)
• MI more than 6 months earlier ( Patients with fewer than 20 Detsky points who have 0 or 1 low-risk variable are considered to be at low risk (< 3% chance of complications), and those with 2 or more variables are considered to be at intermediate risk (3% to 15% chance of complications).
Evaluation steps. Patients who are young, who are undergoing minor surgery, who have no systemic disease, and who require emergency surgery can go directly to the operating room without further testing. For other patients, the next step is to incorporate the Detsky index. A Detsky score of 20 or more is comparable to a major clinical predictor in the ACC/AHA scheme, and it is an indication for further evaluation or treatment prior to surgery.
However, most patients have a Detsky score of 15 points or less, and at this point we consider the aforementioned low-risk variables. Patients with none or only one of these variables can proceed directly to surgery without testing. Likewise, patients with two or more low-risk variables who are undergoing nonvascular surgery require no further testing, but those with two or more low-risk variables who are scheduled for vascular surgery should undergo further noninvasive testing with either dipyridamole-thallium imaging or dobutamine stress echocardiography; also, we should determine their eligibility for beta-blocker therapy if needed. Patients whose imaging results are negative can proceed to surgery, but those with positive results are considered high-risk.
Once a patient is classified as high-risk (> 15% chance of complications) at any point during the evaluation process, we must postpone surgery until we determine the nature of the risk. Patients who have ischemic heart disease should be evaluated to determine if they are suitable candidates for coronary revascularization. If so, reevaluate after revascularization; if not, consider switching to a less risky procedure or canceling surgery.
Patients whose high risk is associated with CHF, arrhythmia, valvular disease, or modifiable risk factors should undergo a trial of optimal medical management and subsequent reassessment of their cardiovascular risks. Again, if optimal treatment or risk factor modification fails, consider switching to a less risky procedure or canceling surgery.
Differences between the ACC/AHA and ACP guidelines
The ACP guidelines are purely evidence-based; without evidence, the ACP makes no recommendation. The ACC/AHA, on the other hand, uses the best evidence available; when evidence is insufficient or lacking, it relies on expert consensus panels to make recommendations. Also, the ACP does not consider exercise capacity and the ACC/AHA does. Likewise, the ACC/AHA uses surgery-specific risk while the ACP divides surgery into vascular and nonvascular categories. In sum, the ACC/AHA tends to recommend more testing than does the ACP.
Other risk assessment systems
In 1999, Lee et al described their simple index, the Revised Cardiac Risk Index, which is based on a study of more than 4,000 patients aged 50 years or older who had undergone major elective noncardiac surgery. 4 They identified six independent predictors of major cardiac complications: (1) high-risk surgery, (2) preoperative treatment with insulin, (3) preoperative serum creatinine level greater than 2 mg/dL, (4) history of ischemic heart disease, (5) history of CHF, and (6) history of cerebrovascular disease.
An absence of these risk factors was associated with a 0.4% to 0.5% risk of a major cardiac complication, and the presence of one risk factor carried a risk of 0.9% to 1.3% (low risk in both cases). The risk was 4% to 7% for patients with two risk factors (intermediate risk) and 9% to 11% for those with three or more risk factors (high risk).
The shortcoming of this system is that the authors did not make any specific recommendations as to what to do with this information; however, subsequent publications did use this index in an algorithm with beta-blockers, 8 as discussed in the next article in this supplement.
In 2005, Kertai et al published their "customized" version of the Revised Cardiac Risk Index, 9 which is based on a point total similar to that used for the Detsky index. The Kertai system is different in that it also subtracts points for use of prophylactic medical therapy (beta-blockers and statins).
■ NONINVASIVE TESTING
Once the risk assessment indicates that further testing is advisable, the next step is to decide which tests are 
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appropriate. Noninvasive testing is usually the preferred first step. The common noninvasive tests are resting two-dimensional echocardiography, exercise stress testing with or without imaging, pharmacologic stress testing with nuclear imaging, and pharmacologic stress testing with echocardiography. Some are more useful than others.
Echocardiography
An ejection fraction of less than 35% may predict postoperative CHF, but it is not a consistent predictor of ischemic events. Therefore, resting two-dimensional echocardiography should not be used preoperatively to evaluate CAD. It might be helpful in a patient with CHF or suspected valvular disease, but it usually does not provide any useful information beyond what we already know clinically.
Exercise stress testing
The dynamic tests measure a patient's functional capacity, which can be impaired by old age, deconditioning, myocardial ischemia, and decreased cardiac or pulmonary reserve. One problem with ordering an exercise test is that we do not know whether the cause of functional impairment is cardiac or noncardiac. Another problem is that most patients cannot complete the test; fewer than half of tested patients reach their target heart rate, so their results are inconclusive. Ischemia at a low level of exercise, however, is significant.
Pharmacologic stress testing with nuclear imaging
Most of these tests use a dipyridamole stressor and thallium contrast. The endpoints are the size and number of reperfusion defects; fixed defects are less important for short-term prognosis. The negative predictive value is good (> 95%), but the positive predictive value is poor (4% to 20%). 2, 10 These tests should not be used in patients with COPD, as dipyridamole may cause bronchospasm, but they are preferred over exercise and dobutamine stress testing for patients with left bundle branch block because the other modalities can yield false-positive results.
Pharmacologic stress testing with echocardiography
These tests are usually performed with dobutamine as a stressor to identify wall-motion abnormalities. The use of dobutamine more closely simulates true exercise in that it increases oxygen demand. Evidence of ischemia at low doses of dobutamine usually indicates more severe disease. Again, the negative predictive value is good (> 93%), but the positive predictive value for serious events is low (7% to 25%).
2,10
■ INVASIVE PROCEDURES
Positive findings on noninvasive testing call for prophylactic measures-either a trial of medical therapy (discussed in the next article in this supplement) or an invasive procedure.
Prophylactic CABG. Keep in mind the fact that coronary artery bypass graft surgery (CABG) carries significant risks of its own. Among patients overall, the average risk of perioperative mortality during CABG is about 1% to 2%, 11 the risk of nonfatal MI is 2% to 5%, 12 and the risk of stroke is 1% to 3%. 13 These rates, of course, are higher in high-risk surgical patients. Nevertheless, observational studies over the years have shown that previous CABG was associated with a lower rate of mortality and nonfatal MI during noncardiac surgery. Among all patients who underwent noncardiac surgery, perioperative mortality was 0.9% for those who had previously undergone CABG and 2.4% for those who had not. The corresponding rates for patients who underwent high-risk noncardiac surgery were 1.7% and 3.3%. Rates of nonfatal MI were 0.7% vs 1.1% overall and 0.8% vs 2.7% during highrisk noncardiac surgery. The protective effect of CABG lasted approximately 4 to 6 years. There was no benefit with CABG in those patients who subsequently underwent a low-risk noncardiac procedure. 14, 15 Percutaneous coronary intervention. Likewise, it appears that percutaneous coronary intervention (PCI) may also lower the risk of perioperative mortality and nonfatal MI (compared with historical controls). Studies suggest that noncardiac surgery should be performed no sooner than 7 to 10 days after balloon angioplasty 16 and no sooner than 4 to 6 weeks after coronary stent placement. [17] [18] [19] [20] However, the prophylactic benefit of placing stents is questionable. A compilation of results from four studies using bare metal stents showed that despite preoperative stenting, complication rates with subsequent noncardiac surgery were high: mortality, 6.9%; nonfatal MI, 5.4%; and hemorrhage, 6.9%. [17] [18] [19] [20] Likewise, drug-eluting stents may not be advisable prior to noncardiac surgery because they delay endothelialization and may require a longer period of dual-antiplatelet therapy (at least 2 to 3 months for sirolimus-coated stents and 6 months for paclitaxel-coated stents).
CABG-PCI study. A multicenter Veterans Administration study of men who underwent prophylactic preoperative CABG or PCI showed that coronary artery revascularization before elective vascular surgery in patients with stable cardiac symptoms did not significantly alter outcome. 21 A few study limita-tions notwithstanding, including the fact that both groups were treated with intensive medical therapy, the authors could not recommend prophylactic revascularization. On the other hand, revascularization may be appropriate for patients with unstable or more severe cardiac symptoms. Pulmonary artery catheterization. Although pulmonary artery catheterization might detect hemodynamic disorders that could lead to a change in treatment, there is no evidence that it prevents perioperative cardiac morbidity or mortality. 22 It might benefit the type of patients who are usually excluded from these clinical trials--eg, those with a recent MI, pulmonary edema, CHF, chronic kidney disease, or valvular disease-who undergo major surgery.
■ SUMMARY
The history and the physical examination remain the most important elements in cardiac risk stratification of patients prior to noncardiac surgery. Indications for further cardiac tests and interventions are usually the same as in the nonsurgical setting. No test should be performed unless the results will affect patient management. In many cases, noninvasive testing is being replaced by prophylactic medical therapy, a topic explored in the next article in this supplement.
